BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 39 filers reported holding BIOTA PHARMACEUTIALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $0 | – | 101 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 101 | 0.0% | 0.00% | – |
| Q3 2015 | $0 | – | 101 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | – | 101 | -50.0% | 0.00% | – |
| Q1 2015 | $0 | – | 202 | +45.3% | 0.00% | – |
| Q4 2014 | $0 | – | 139 | 0.0% | 0.00% | – |
| Q3 2014 | $0 | – | 139 | 0.0% | 0.00% | – |
| Q2 2014 | $0 | -100.0% | 139 | -99.2% | 0.00% | – |
| Q1 2014 | $100,000 | +9900.0% | 16,420 | +11712.9% | 0.00% | – |
| Q4 2013 | $1,000 | – | 139 | +13800.0% | 0.00% | – |
| Q3 2013 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2013 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 327,190 | $1,371,000 | 1.41% |
| Healthcare Value Capital, LLC | 204,639 | $857,000 | 0.63% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 387,048 | $1,622,000 | 0.59% |
| TOWERVIEW LLC | 285,000 | $1,194,000,000 | 0.55% |
| 683 Capital Management, LLC | 450,000 | $1,886,000 | 0.54% |
| Dominick & Dominick LLC | 88,089 | $369,000 | 0.18% |
| Baker Brothers Advisors | 1,130,113 | $4,735,000 | 0.07% |
| SHEPHERD KAPLAN KROCHUK, LLC | 50,299 | $211,000 | 0.03% |
| Spark Investment Management LLC | 18,100 | $75,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 79,899 | $335,000 | 0.01% |